• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《伊比利亚美洲地区同型合子家族性高胆固醇血症成人和儿童的表型、临床和分子特征》

Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.

机构信息

Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal (A.C.A., A.M.M., M.B.).

Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis, Unidade de I&D, Grupo de Investigação Cardiovascular, Lisboa, Portugal (A.C.A., A.M.M., M.B.).

出版信息

Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2508-2515. doi: 10.1161/ATVBAHA.120.313722. Epub 2020 Aug 6.

DOI:10.1161/ATVBAHA.120.313722
PMID:32757650
Abstract

OBJECTIVE

Characterize homozygous familial hypercholesterolemia (HoFH) individuals from Iberoamerica. Approach and Results: In a cross-sectional retrospective evaluation 134 individuals with a HoFH phenotype, 71 adults (age 39.3±15.8 years, 38.0% males), and 63 children (age 8.8±4.0 years, 50.8% males) were studied. Genetic characterization was available in 129 (96%). The majority (91%) were true homozygotes (true HoFH, n=79, 43.0% children, 46.8% males) or compound heterozygotes (compound heterozygous familial hypercholesterolemia, n=39, 51.3% children, 46.2% males) with putative pathogenic variants in the . True HoFH due to variants had higher total (=0.015) and LDL (low-density lipoprotein)-cholesterol (=0.008) compared with compound heterozygous familial hypercholesterolemia. Children with true HoFH (n=34) tended to be diagnosed earlier (=0.051) and had a greater frequency of xanthomas (=0.016) than those with compound heterozygous familial hypercholesterolemia (n=20). Previous major cardiovascular events were present in 25 (48%) of 52 children (missing information in 2 cases), and in 43 (67%) of 64 adults with variants. Children who are true HoFH had higher frequency of major cardiovascular events (=0.02), coronary heart (=0.013), and aortic/supra-aortic valve diseases (=0.022) than compound heterozygous familial hypercholesterolemia. In adults, no differences were observed in major cardiovascular events according to type of variant. From 118 subjects with variants, 76 (64%) had 2 likely pathogenic or pathogenic variants. In 89 subjects with 2 variants, those with at least one null allele were younger (=0.003) and had a greater frequency of major cardiovascular events (=0.038) occurring at an earlier age (=0.001).

CONCLUSIONS

There was a high frequency of cardiovascular disease even in children. Phenotype and cardiovascular complications were heterogeneous and associated with the type of molecular defect.

摘要

目的

描述伊比利亚美洲的纯合家族性高胆固醇血症(HoFH)个体。

方法和结果

在一项横断面回顾性评估中,研究了 134 名具有 HoFH 表型的个体,其中 71 名成年人(年龄 39.3±15.8 岁,38.0%为男性)和 63 名儿童(年龄 8.8±4.0 岁,50.8%为男性)。129 名(96%)可进行基因特征分析。大多数(91%)为纯合子(真 HoFH,n=79,43.0%为儿童,46.8%为男性)或复合杂合子(杂合子家族性高胆固醇血症,n=39,51.3%为儿童,46.2%为男性),携带. 种变异的真 HoFH 总胆固醇(=0.015)和 LDL 胆固醇(=0.008)更高。与复合杂合子家族性高胆固醇血症相比,患有真 HoFH(n=34)的儿童倾向于更早被诊断(=0.051),且黄色瘤的发生率更高(=0.016)。52 名儿童中有 25 名(48%)(2 例缺失信息)和 64 名成年人中有 43 名(67%)(携带 种变异)发生过重大心血管事件。患有真 HoFH 的儿童发生重大心血管事件(=0.02)、冠心病(=0.013)和主动脉/升主动脉瓣疾病(=0.022)的频率高于复合杂合子家族性高胆固醇血症。在成年人中,根据 种变异类型,重大心血管事件无差异。在 118 名携带 种变异的受试者中,76 名(64%)携带 2 种可能致病或致病性变异。在 89 名携带 2 种变异的受试者中,至少有一种缺失等位基因的患者更年轻(=0.003),且更早发生重大心血管事件(=0.038)。

结论

即使在儿童中,心血管疾病的发生率也很高。表型和心血管并发症具有异质性,与分子缺陷类型相关。

相似文献

1
Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.《伊比利亚美洲地区同型合子家族性高胆固醇血症成人和儿童的表型、临床和分子特征》
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2508-2515. doi: 10.1161/ATVBAHA.120.313722. Epub 2020 Aug 6.
2
Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.西班牙的纯合子家族性高胆固醇血症:患病率及表型-基因型关系
Circ Cardiovasc Genet. 2016 Dec;9(6):504-510. doi: 10.1161/CIRCGENETICS.116.001545. Epub 2016 Oct 26.
3
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.纯合子家族性高胆固醇血症患者携带相同的 LDLR(低密度脂蛋白受体)突变,其表达可变:对依洛尤单抗疗效的影响。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):592-598. doi: 10.1161/ATVBAHA.117.310217. Epub 2017 Dec 28.
4
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features.意大利家族性高胆固醇血症纯合子患者:临床和分子特征。
Atherosclerosis. 2020 Nov;312:72-78. doi: 10.1016/j.atherosclerosis.2020.08.027. Epub 2020 Sep 9.
5
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.意大利家族性高胆固醇血症患者的突变谱:LIPIGEN研究的新结果。
Atheroscler Suppl. 2017 Oct;29:17-24. doi: 10.1016/j.atherosclerosissup.2017.07.002.
6
Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.南非家族性高胆固醇血症的级联筛查:威特斯 FIND-FH 项目。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2747-2755. doi: 10.1161/ATVBAHA.120.315040. Epub 2020 Sep 3.
7
DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.在全国范围内设计(DIAMOND-FH)中诊断和管理家族性高胆固醇血症:瑞士的流行情况、临床特征和临床评分的诊断价值。
Atherosclerosis. 2018 Oct;277:282-288. doi: 10.1016/j.atherosclerosis.2018.08.009.
8
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.杂合子家族性高胆固醇血症患者的致病突变与早发性心血管疾病
Eur J Prev Cardiol. 2017 Jul;24(10):1051-1059. doi: 10.1177/2047487317702040. Epub 2017 Mar 29.
9
Molecular genetics of familial hypercholesterolemia in Israel-revisited.以色列家族性高胆固醇血症的分子遗传学研究回顾。
Atherosclerosis. 2017 Feb;257:55-63. doi: 10.1016/j.atherosclerosis.2016.12.021. Epub 2016 Dec 18.
10
Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia.通过长读测序在临床诊断为杂合子家族性高胆固醇血症的患者中鉴定纯合子家族性高胆固醇血症。
Circ Genom Precis Med. 2023 Apr;16(2):e003887. doi: 10.1161/CIRCGEN.122.003887. Epub 2023 Mar 24.

引用本文的文献

1
Homozygous Familial Hypercholesterolemia in Canada: An Observational Study.加拿大的纯合子家族性高胆固醇血症:一项观察性研究。
JACC Adv. 2023 Apr 26;2(3):100309. doi: 10.1016/j.jacadv.2023.100309. eCollection 2023 May.
2
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia.12个单核苷酸多态性和6个单核苷酸多态性多基因评分对家族性高胆固醇血症患者高LDL-胆固醇水平易感性的影响。
Genes (Basel). 2024 Apr 6;15(4):462. doi: 10.3390/genes15040462.
3
Clinical Characteristics of Homozygous Familial Hypercholesterolemia in Japan: A Survey Using a National Database.
日本纯合子家族性高胆固醇血症的临床特征:一项基于全国数据库的调查
JACC Asia. 2023 Sep 19;3(6):881-891. doi: 10.1016/j.jacasi.2023.07.011. eCollection 2023 Dec.
4
Paradoxical Findings in Homozygous Familial Hypercholesterolemia in Japan: Longer Life But Still Not Totally Better!日本纯合子家族性高胆固醇血症的矛盾发现:寿命延长但仍不尽如人意!
JACC Asia. 2023 Nov 7;3(6):892-894. doi: 10.1016/j.jacasi.2023.09.008. eCollection 2023 Dec.
5
Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome.与代谢综合征相关的致动脉粥样硬化性血脂异常遗传因素的当前数据及新见解
Diagnostics (Basel). 2023 Jul 12;13(14):2348. doi: 10.3390/diagnostics13142348.
6
Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.代谢系统方法更新了对纯合家族性高胆固醇血症患者临床表型和心血管风险的分子认识。
BMC Med. 2023 Jul 27;21(1):275. doi: 10.1186/s12916-023-02967-8.
7
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.当代美国纯合子家族性高胆固醇血症:来自 CASCADE FH 注册研究的见解。
J Am Heart Assoc. 2023 May 2;12(9):e029175. doi: 10.1161/JAHA.122.029175. Epub 2023 Apr 29.
8
New Trends and Therapies for Familial Hypercholesterolemia.家族性高胆固醇血症的新趋势与治疗方法
J Clin Med. 2022 Nov 9;11(22):6638. doi: 10.3390/jcm11226638.
9
Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia.低密度脂蛋白受体基因型可改变纯合子家族性高胆固醇血症患者的血清代谢组。
iScience. 2022 Oct 12;25(11):105334. doi: 10.1016/j.isci.2022.105334. eCollection 2022 Nov 18.
10
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases.同种异体家族性高胆固醇血症的肝移植是否具有治疗效果?全球九例病例综述。
Adv Ther. 2022 Jun;39(6):3042-3057. doi: 10.1007/s12325-022-02131-3. Epub 2022 Apr 26.